CLINICAL_TRIALS
trial_result
· 2025-07-31
Clinical Trial Update: Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial [Phase 2]
Summary
Phase 2 randomized trial of cellular immunotherapy for COVID-19–related acute respiratory distress syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Covid19, Acute Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED